John Anthony Panuto, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 25761 Lorain Rd, 3rd Fl, North Olmsted, OH 44070 Phone: 440-779-1112 Fax: 440-779-0247 |
Lauren Fill, DO Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 25761 Lorain Rd, North Olmsted, OH 44070 Phone: 440-779-1112 Fax: 440-779-0247 |
News Archive
America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.
Today the national headquarters of Susan G. Komen reversed its decision regarding funding to Planned Parenthood. The organization apologized to the American public for decisions that cast doubt upon their commitment to their mission of saving lives.
A new paper from MIT neuroscientists, in collaboration with Alvaro Pascual-Leone at Beth Israel Deaconess Medical Center, offers evidence that it is easier to rewire the brain early in life. The researchers found that a small part of the brain's visual cortex that processes motion became reorganized only in the brains of subjects who had been born blind, not those who became blind later in life.
By swapping replacement parts into the backbone of a synthetic hormone, UW-Madison graduate student Ross Cheloha and his mentor, Sam Gellman, along with collaborators at Harvard Medical School, have built a version of a parathyroid hormone that resists degradation in laboratory mice.
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
› Verified 6 days ago